GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder

@article{Deckert2017GLRBAV,
  title={GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder},
  author={Jake Andrew Deckert and Heike Weber and Carmen Villmann and Tina B. Lonsdorf and Jan Richter and Marta Andreatta and Alejandro Arias-Vasquez and Leif G. Hommers and Lindsey Kent and Christoph Schartner and Sven Cichon and Christiane Wolf and Nancy Schaefer and Cora R. von Collenberg and Britta Wachter and R. Doutor Heitor Blum and Dirk Sch{\"u}mann and Robert Scharfenort and Johannes Schumacher and A J Forstner and Christian Baumann and Miriam A. Schiele and Swantje Notzon and Peter Zwanzger and Joost G. E. Janzing and Tessel E. Galesloot and Lambertus A.L.M. Kiemeney and Agnieszka Gajewska and Evelyn Glotzbach-Schoon and Andreas M{\"u}hlberger and Georg W. Alpers and Thomas Fydrich and Lydia Fehm and Alexander L. Gerlach and Tilo T. J. Kircher and Thomas Lang and Andreas Str{\"o}hle and Volker Arolt and Hans-Ulrich Wittchen and Raffael Kalisch and Christian B{\"u}chel and Alfons O. Hamm and Markus M. N{\"o}then and Marcel Romanos and Katharina Domschke and Paul Pauli and Andreas Reif},
  journal={Molecular Psychiatry},
  year={2017},
  volume={22},
  pages={1431-1439}
}
The molecular genetics of panic disorder (PD) with and without agoraphobia (AG) are still largely unknown and progress is hampered by small sample sizes. We therefore performed a genome-wide association study with a dimensional, PD/AG-related anxiety phenotype based on the Agoraphobia Cognition Questionnaire (ACQ) in a sample of 1370 healthy German volunteers of the CRC TRR58 MEGA study wave 1. A genome-wide significant association was found between ACQ and single non-coding nucleotide variants… 

Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes

The present results provide converging evidence for an involvement of HCRTR1 gene variation in the etiology of PD/AG and PD/ AG-related traits as well as treatment response to CBT, supporting future therapeutic approaches targeting the orexin-related arousal system.

The effect of polymorphisms in startle-related genes on anxiety symptom severity.

Genetics of human startle reactivity: A systematic review to acquire targets for an anxiety endophenotype

Startle reactivity is a promising endophenotype that requires concerted efforts to collect uniformly assessed, large, well-powered samples and hypothesis-free genome-wide strategies, and this review suggests advanced genetic strategies for startle research.

Modulation of defensive reactivity by GLRB allelic variation: converging evidence from an intermediate phenotype approach

Findings provide translational evidence for glycine neurotransmission as a modulator of the brain’s evolutionary old dynamic defensive system and provide further support for a strong, biologically plausible candidate intermediate phenotype of defensive reactivity.

Metanalysis of genome-wide association studies for panic disorder suggest pathways and mechanisms of pathogenesis

A meta-analysis of genome-wide association studies of patients with PD found 25 single-nucleotide polymorphisms that were associated with the disorder, and ASB3, EIF2S2, RASGRF2, and TRMT2B (and its coded proteins) emerged as interesting targets for mechanistic research on PD.

Genetic and epigenetic analyses of panic disorder in the post-GWAS era

Evidence remains insufficient to confidently identify or exclude rare variants or epigenetic changes in PD, and further analyses are required, using sample sizes in the tens of thousands, extensive functional annotations, and highly targeted hypothesis testing.

Anxiety and Startle Phenotypes in Glrb Spastic and Glra1 Spasmodic Mouse Mutants

Two mouse models harboring either a mutation in the murine Glra1 or Glrb gene with regard to anxiety and startle phenotypes are compared and heterozygous spastic animals revealed no startle phenotype in a neutral as well as a conditioning context.

DNA methylation in adolescents with anxiety disorder: a longitudinal study

Investigating a cohort of adolescents and young adults according to the AD diagnosis and their longitudinal trajectories found decreased DNA methylation in TDC group while the chronic cases of AD presented hypermethylation in central nervous system development pathways.

References

SHOWING 1-10 OF 70 REFERENCES

MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy

It is established that a genetic risk factor for PD/AG is associated with worse response to CBT and potential underlying neural mechanisms are established, which might govern how psychotherapy can include genetic information to tailor individualized treatment approaches.

Replication and meta-analysis of TMEM132D gene variants in panic disorder

The present results support the initial finding that TMEM132D gene contributes to genetic susceptibility for PD in individuals of EA and indicate that patient ascertainment and genetic background could be important sources of heterogeneity modifying this association signal in different populations.

Neuropeptide S receptor gene — converging evidence for a role in panic disorder

Animal studies have suggested neuropeptide S (NPS) and its receptor (NPSR) to be involved in the pathogenesis of anxiety-related behavior. In this study, a multilevel approach was applied to further

Genome-wide association study of panic disorder in the Japanese population

Seven SNPs were significantly associated with PD, which were located in or adjacent to genes including PKP1, PLEKHG1, TMEM16B, CALCOCO1, SDK2 and CLU (or APO-J).

ADORA2A Gene Variation, Caffeine, and Emotional Processing: A Multi-level Interaction on Startle Reflex

The data point to a complex, multi-level, and potentially gender-specific pathogenetic model of anxiety, with genetic and biochemical factors interactively increasing the risk of maladaptive emotional processing and thereby possibly also anxiety disorders.

Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing

The role of CRHR1 in PD is strengthened and the mechanisms by which genetic variation inCRHR1 is linked to this disorder are clarified, as reduced gene expression driven by CRHS risk allele leads to a phenotype characterized by fear sensitization and hence sustained fear.

Panic disorder with agoraphobia from a behavioral neuroscience perspective: Applying the research principles formulated by the Research Domain Criteria (RDoC) initiative.

This review reconceptualizes a categorical diagnosis-panic disorder and agoraphobia-in terms of two constructs within the domain "negative valence systems" suggested by the Research Domain Criteria initiative and finds evidence that panic attacks are indeed instances of circa strike defense.

Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus.

The findings support the notion that the major anxiety disorders, including phobias and panic disorder, are complex traits that share at least one susceptibility locus.

Genetic and environmental influences on the co‐morbidity between depression, panic disorder, agoraphobia, and social phobia: a twin study

The high genetic correlation between PD and AG and the increased odds ratio forPD and AG in siblings of those with AG without PD suggests a common genetic etiology for PD andAG.

Advances in molecular genetics of panic disorder

The recent advantages in bioinformatics and genotyping technologies, including genome-wide association and gene expression methods, provide the means for far more comprehensive discovery in PD.
...